-+ 0.00%
-+ 0.00%
-+ 0.00%

Xilio Therapeutics Announces 1-For-14 Reverse Stock Split, Effective March 13

Benzinga·03/12/2026 12:32:23
Listen to the news

Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced that it will implement a 1-for-14 reverse stock split of the issued shares of the company's common stock, effective at 5:00 p.m. Eastern Time on March 13, 2026.